
Featured45 Days Late: Why Copying 13F Filings Doesn't Work — and What They're Actually Good For
A 13F is a photo taken 45 days ago, half cropped out, with makeup on. The information dividend lasts about two days — and it's long gone.
What's on your mind?

A 13F is a photo taken 45 days ago, half cropped out, with makeup on. The information dividend lasts about two days — and it's long gone.

$Charles Schwab(SCHW.US) Q1 results were decent, but expectations were lofty. The market may flag a slight revenue miss and a QoQ decline in NIM.
After a strong Feb operating update, management guided to 16% Q1 revenue growth (vs. 14.5% then-consensus). That effectively raised the bar a month early.1) Key metrics — NNA and NIM. For now, if we boil Schwab’s biz down to the basics...$Recursion Pharmaceuticals(RXRX.US) has a distinctive equity structure characterized by **"backing from AI giants, clustering of well-known growth funds, and regular founder share reductions"**. As of the latest data in December 2025, here is a detailed summary of RXRX's institutional ownership and core team holdings: 1. Institutional Ownership Overview Institutional investors currently hold approximately 60% - 70% of RXRX's outstanding shares...
$Rocket Lab(RKLB.US)’s equity structure exhibits the characteristics of **"heavy institutional holdings, founder control (influence), early venture capital gradually exiting but still holding a significant portion"**. As of the latest data in December 2025, here is a detailed summary of RKLB's institutional holdings and core team holdings: 1. Institutional Ownership Overview Institutional investors currently hold approximately 50%-60% of RKLB's outstanding shares. Among them...